Browse Arkansas Code titles and sections
23-79-1303. Coverage for prostate cancer screening required.
Arkansas Code — all titles (historical 2020) · legal_authorities
23-79-1303. Coverage for prostate cancer screening required.
(a)(1) A health benefit plan that is offered, issued, or renewed in this state on or after January 1, 2010, and that provides coverage to men forty (40) years of age or older in this state shall provide coverage for screening for the early detection of prostate cancer in men forty (40) years of age and older according to the National Comprehensive Cancer Network guidelines, as in effect on January 1, 2009.
(2) The coverage for prostate cancer screening required under subdivision (a)(1) of this section:
(A) Is not subject to policy deductibles; and
(B) Shall not exceed the actual cost of the prostate cancer screening up to the maximum allowable cost per screening.
(b) The coverage for prostate cancer screening required under subsection (a) of this section shall be offered as follows:
(1) The prostate cancer screening shall be performed by a qualified medical professional; and
(2) The coverage shall provide at least one (1) screening per year for any man forty (40) years of age or older according to the National Comprehensive Cancer Network guidelines, as in effect on January 1, 2009.
(c) The coverage for prostate cancer screening required under subsection (a) of this section does not diminish or limit diagnostic benefits otherwise allowable under a health benefit plan.
(d) If a medical practitioner recommends that an insured, a subscriber, or an enrollee undergo a prostate specific antigen blood test, coverage may not be denied on the ground that the insured, subscriber, or enrollee has already had a digital rectal examination and the examination result was negative.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 23-79-1303
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:23-79-1303
Source file: gov.ar.code.title.23.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 2e14123e7cdc04d312879350a402e2ec7510f805f3ae9918b2fbf384de616d8f
Source location: content.xml paragraph 47883
Stored source content
23-79-1303. Coverage for prostate cancer screening required.
(a)(1) A health benefit plan that is offered, issued, or renewed in this state on or after January 1, 2010, and that provides coverage to men forty (40) years of age or older in this state shall provide coverage for screening for the early detection of prostate cancer in men forty (40) years of age and older according to the National Comprehensive Cancer Network guidelines, as in effect on January 1, 2009.
(2) The coverage for prostate cancer screening required under subdivision (a)(1) of this section:
(A) Is not subject to policy deductibles; and
(B) Shall not exceed the actual cost of the prostate cancer screening up to the maximum allowable cost per screening.
(b) The coverage for prostate cancer screening required under subsection (a) of this section shall be offered as follows:
(1) The prostate cancer screening shall be performed by a qualified medical professional; and
(2) The coverage shall provide at least one (1) screening per year for any man forty (40) years of age or older according to the National Comprehensive Cancer Network guidelines, as in effect on January 1, 2009.
(c) The coverage for prostate cancer screening required under subsection (a) of this section does not diminish or limit diagnostic benefits otherwise allowable under a health benefit plan.
(d) If a medical practitioner recommends that an insured, a subscriber, or an enrollee undergo a prostate specific antigen blood test, coverage may not be denied on the ground that the insured, subscriber, or enrollee has already had a digital rectal examination and the examination result was negative.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
No explicit source connection was found. This does not mean there are no relevant authorities.